Skip to main

Winship investigators to share latest discoveries at AACR Annual Meeting

The 2026 AACR Annual Meeting will be held at the San Diego Convention Center. (Photo: Ian McDonnell/iStock.com)

Researchers and clinicians from Winship Cancer Institute of Emory University will lead sessions and present new findings at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, April 17-22.

Organized around the theme “Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally,” the 2026 AACR Annual Meeting is expected to bring together more than 22,000 participants from around the world to share scientific breakthroughs and accelerate progress against cancer.

With 43 presentations, Winship faculty, trainees and coalition partners will share discoveries designed to improve prevention, detection, treatment and survivorship of more than a dozen different cancers. Many of the studies showcase the use of emerging technologies to deliver more precise, durable and accessible therapies, underscoring Winship’s commitment to advancing patient-centered cancer care.

Schedule of Winship presentations

10:30 a.m. – 10:50 a.m.
Location: Ballroom 20 AB – Upper Level – Convention Center | Educational Session | Tumor Immunology For Non Immunologists: Back to Basics
2:30 p.m. – 4:00 p.m.
Location: Room 30 – Upper Level – Convention Center | Educational Session | Manufacturing and Engineering the Next Generation of Immune Effectors
2:00 p.m. – 5:00 p.m.
Location: Section 4 | Poster Session | Digital Pathology 1
Location: Section 46 | Poster Session | Prognostic Biomarkers 1
Location: Section 34 | Poster Session | Survivorship Research
9:00 a.m. – 12:00 p.m.
Location: Section 20 | Poster Session | Cell Cycle
Location: Section 36 | Poster Session | Epidemiology: Cancer Incidence, Mortality, Patterns, and Methodology
1:00 p.m. – 1:20 p.m.
Location: Room 31 – Upper Level | Major Symposium | Programmed Cell Death: Mechanisms and Therapeutic Opportunities
2:00 p.m. – 5:00 p.m.
Location: Section 47 | Poster Session | Molecular Targeted Therapy
Location: Section 7 | Poster Session | Immune Checkpoints
Location: Section 13 | Poster Session | Molecular Targets 1
Location: Section 14 | Poster Session | Nanocarriers and Drug Delivery Systems
Location: Section 15 | Poster Session | Novel Targets and Pathways
Location: Section 35 | Poster Session | Genetic Epidemiology
Location: Section 36 | Poster Session | Metabolism and Microbiome in Cancer Initiation and Prevention
Location: Section 43 | Poster Session | Combination Immunotherapies
Location: Section 53 | Late-Breaking Poster Session | Experimental and Molecular Therapeutics 2
Location: Section 55 | Late-Breaking Poster Session | Tumor Biology 1
2:30 p.m. – 4:30 p.m.
Location: Room 31 – Upper Level – Convention Center | Minisymposium | Digital Pathology
8:05 a.m. – 8:33 a.m.
Location: Hall H – Ground Level | Plenary Session | Early-Onset Cancers
9:00 a.m. – 12:00 p.m.
Location: Section 24 | Poster Session | Oncogenic Transcription Factors and Cancer Programs
Location: Section 25 | Poster Session | Angiogenesis
Location: Section 36 | Poster Session | Etiology and Molecular Epidemiology
Location: Section 31 | Poster Session | Spatial Niches and Functional Boundaries
Location: Section 35 | Poster Session | Diet, Alcohol, and Tobacco
Location: Section 54 | Late-Breaking Poster Session | Molecular/Cellular Biology and Genetics 2
Location: Section 55 | Late-Breaking Poster Session | Tumor Biology 2
2:00 p.m. – 5:00 p.m.
Location: Section 26 | Poster Session | In Vivo Models
Location: Section 42 | Poster Session | Combination Targeted Therapy
2:35 p.m. – 2:50 p.m.
Location: Ballroom 6A – Upper Level | Minisymposium | Aging Micro- and Macro-Environments
3:00 p.m. – 4:00 p.m.
Location: Spotlight Theater C – Sails Pavilion | Exhibitor Spotlight Presentation
9:00 a.m. – 12:00 p.m.
Location: Section 9 | Poster Session | Tumor-induced Immune Suppression
Location: Section 11 | Poster Session | Drug Resistance 2: Tyrosine Kinase Inhibitors
Location: Section 14 | Poster Session | Novel Strategies to Reverse Drug Resistance
Location: Section 47 | Poster Session | Targeted Therapies in Pediatric Cancers